Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease

Clinical trial NCT00074919 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT00074919
Sponsor: Genzyme, a Sanofi Company
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Glycogen Storage Disease Type II Glycogenosis 2

Start date: 2003-12-01
Primary completion: 2007-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.